Ochsner Health announced Paul J. Kenny, PhD as the 2020 recipient of the annual Alton Ochsner Award Relating Smoking and Disease, which recognizes scientific research achievements that provide major insights into the biological mechanisms relating tobacco smoking and human disease.
July 8, 2020—Ochsner Health, Louisiana's largest non-profit academic healthcare system, annouced Paul J. Kenny, PhD, as the recipient of the 35th annual Alton Ochsner Award Relating Smoking and Disease. Kenny is a Ward-Coleman professor and chair of the Nash Family Department of Neuroscience at the Icahn School of Medicine at Mount Sinai in new York.
The award is named after Alton Ochsner, MD, who, in 1939, published the first evidence indicating tobacco smoking was the makor cause of lung cancer. Kenny's research focused on nicotine addiction and provided insights for the development of new treatment methods. In particular, Kenny demonstrated the relevance of glucagon-like peptide to the regulation of nicotine craving.
"As our 2020 honoree, Dr. Kenny joins the ranks of other research giants in this field for his contributions studying nicotine addition,” said Leonardo Seoane, MD, chief academic officer of Ochsner Health.
Read the full press release here.